KeyStone Center provides Medically Monitored Detoxification and Rehabilitation for individuals struggling with addiction to drugs and/or alcohol.
With an average length of stay of three to eight days, depending on the type of detoxification needed, this program is designed for individuals with chronic substance abuse and dual diagnosis issues who are in need of treatment.
Patients who may have been unsuccessful in past treatment and recovery attempts, with numerous relapses, and whose addiction has significantly impacted their ability to live productive lives may be appropriate for this program. Stabilizing a patient’s mental and physical health, educating them on their condition, and beginning the healing process are the primary goals of the program.
The program focuses on problem identification and building a foundation for learning and changing based on the Stages of Change Model and facilitated through Motivational Interviewing, DBT, Cognitive Behavior Therapy as well as many other evidence-based techniques.
Clients begin to uncover primary issues and perpetuating factors to each patient’s current situation. Detrimental lifestyle patterns are identified and the process of change is begun. Treatment care plans will guide a systematic approach to behavioral practice of new ways of dealing with difficult situations, past and present stressors, and adjustment to sobriety.
The program philosophy is to take the patient through exploration of all aspects of his/her life. Each patient has a primary case manager and interacts with many other staff members on the treatment team.
Each day, patients participate in a core therapy group along with several psychoeducational seminars, lectures and experiential task groups. The staff plays a large role in exploring the roots of each patient’s condition along with identifying potential barriers to growth.
Supportive clinical staff members assist the patient in facing and overcoming daily challenges while guiding them toward a more constructive lifestyle.
Near the end of each patient’s treatment, KeyStone’s aftercare specialists begin to develop a plan for post-treatment life. Patients will explore alternate, supportive living arrangements; ongoing treatment options; services available; and a host of other elements to make this recovery attempt more successful.
Topics Addressed During Treatment Include:
Introduction to the 12 Steps
Stages of Change
Mental Health Symptoms Management
Anger Management / Coping Skills
Men’s and Women’s Issues
Parenting and Relationship Issues
Building and Using a Sober Support Network
Access to Community Resources
Self Expression and Change
Detoxification refers to the process whereby a patient stops taking the addictive drug or substance of choice, then over a variable period of time, clears the drug from his or her body to become clean, or abstinent.
A person is said to be addicted when he/she uses a substance in a compulsive manner and develops a tolerance or requirement for increasing amounts of the drug in order to feel high, as well as cravings for the substance when not using it. The addicted person may take the substance in excessive amounts and is often unable to limit or control the amount or frequency of use. Often, this pattern of using interferes with the person’s ability to function in daily life.
Detoxification often marks the end of a “run” or episode of use. Abrupt discontinuation of substances of abuse such as alcohol, opiates and benzodiazepines may produce withdrawal, a syndrome of discomfort, and various signs and symptoms of autonomic overactivity such as tremor; elevated pulse; sweating and insomnia, even seizures in some cases, as well as cravings for the substance. Medically supervised detoxification provides a physician-guided process for safely discontinuing substances of abuse. During an interview the psychiatrist or nurse practitioner assesses the extent, duration and various consequences of the substance use to determine a starting point for detoxification.
Specific protocols address different categories of substance such as alcohol, benzodiazepines, or opiates. Medications are prescribed by the physician which will relieve the symptoms of withdrawal, thereby increasing comfort, while reducing the risk of undesirable outcomes.
The staff at KeyStone Center is highly experienced in the diagnosis and treatment of Opioid Use Disorder (OUD). In order to promote patient safety and reduce the risk of relapse and potential fatal overdose following discharge, KeyStone Center follows current best-practice, evidence-based guidelines for the treatment of Opioid Use Disorder and is pleased to offer two options for medication assisted treatment (MAT).
Upon admission to KeyStone Center, following an initial screening by the admissions staff, the patient is shown to his or her room, then evaluated by nursing and medical staff, to assess for signs and symptoms of opiate withdrawal. Patients who have a history consistent with opiate dependency and present in opiate withdrawal have the option of detoxification with buprenorphine, or induction onto a maintenance therapy, also utilizing Suboxone (buprenorphine-naloxone).
The KeyStone Center protocol for Suboxone maintenance involves a single daily dose of 12 mg, which is continued throughout the residential treatment stay here. Most of our patients on Suboxone maintenance find this to be a suitable arrangement. Some patients decline maintenance therapy with Suboxone however, and, after detoxification, may choose to start monthly injections of the opiate antagonist naltrexone.
Because we strongly feel the choice of a specific MAT is one of the most important decisions that a patient with Opioid Use Disorder can make, we devote the necessary time and attention required to help individuals sort through any logistical issues and ambivalent feelings. Our view is that either option benefits the individual recovering from Opiate Use Disorder and may provide a vital, even life-saving advantage following inpatient residential treatment. We believe that MAT for Opioid Use Disorder offers a distinct advantage over other, abstinence-based approaches, although we do respect an individual’s right to choose whether MAT is suitable for him/her.
Benefits of Subutex:
Subutex administration can ease the symptoms of withdrawal associated with detoxification from heroin, oxycontin and other opiates.
Subutex has been endorsed as being safe and effective by the Food and Drug Administration.
Subutex is easy to administer and binds to the same receptors as other opioid drugs. It mimics the effects of other opioids by alleviating cravings and withdrawal symptoms. This allows you to address the psychosocial reasons behind your opioid use.
Subutex allows patients to engage in rehabilitation services without as much discomfort
Once Subutex is administered it takes effect within 30 minutes.
Patients who may not be appropriate for Subutex include:
Individuals with recent, prolonged exposure to Methadone.
Females who are pregnant.
Patients with active liver or pancreatic disease.
Patients who are cross addicted to sedatives including benzodiazepines, barbiturates or alcohol while not excluded require a dual taper and special precautions due to potentially life-threatening additive sedative effects.
When a person experiences a mental health problem at the same time they are struggling with an addiction to drugs and/or alcohol, they may be diagnosed as having a co-occurring disorder. The KeyStone Center is OMHSAS licensed as a co-occurring disorders center fulfilling all requirements to provide services to patients suffering dual diagnoses.
Some common examples might include alcohol dependence and Major Depressive Disorder, cocaine abuse and Bipolar Mood Disorder, or Xanax dependence and Generalized Anxiety Disorder.
People often ask which problem comes first; however, there is no specific direction or “one way” in which a co-occurring disorder develops. In other words, people are just as likely to be addicted to drugs/alcohol and then develop a mental health problem as they are to having a mental health problem that leads to addiction.
Regardless of which came first, it is very important to understand the current relationship between a person’s mental health problems and their addiction as this provides information about how each condition can impact the other.
At the KeyStone Center, our philosophy of treating co-occurring disorders is to:
Acknowledge the importance of addressing our clients’ mental health and addiction problems simultaneously
Help our clients understand how the two issues affect one another
Provide our clients with multidisciplinary treatment approaches to holistically address their concerns.
We provide a variety of services including: psychiatric evaluations to determine the need for mood stabilizing medications; individual (i.e. one-on-one) psychology consultations that allow people to express, identify, and develop coping skills to manage their concerns; group/family therapy to provide interpersonal strategies to openly and honestly discuss their problems with others; and educational seminars to teach our clients about topics in mental health and addiction/recovery.
Left unaddressed, a co-occurring disorder can lead a person to experience significant and devastating consequences in their lives. Our goal at the KeyStone Center is to provide you or your loved ones with the comprehensive treatment that they deserve to begin the process of addressing their co-occurring addiction and mental health problems.
An Environment of Compassion
KeyStone Center provides treatment for addiction and co-occurring issues at our facility five miles south of Philadelphia International Airport in Delaware County, Pennsylvania. We provide addiction services to patients from all over the country.
We offer no-cost, confidential assessments 24 hours a day, 7 days a week. If you or a loved one are struggling with addiction, call us today at 610-876-9000.